Ultrasound Devices Market

Market Overview:

The global ultrasound devices market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.10% during 2023-2028.

An ultrasound scan, also known as sonography, is a medical examination recording real-time images of the interior of the body using high-frequency sound waves. It helps medical professionals diagnose problems of the bladder, eyes, gallbladder, kidneys, liver, ovaries, pancreas, spleen, thyroid, testicles, uterus, and blood vessels without incision. It also assists in viewing a developing fetus during pregnancy as ultrasound does not rely on radiation as compared to other imaging techniques. Besides this, it is used to guide a needle for biopsy or tumor treatment, examine a breast lump, check the thyroid gland, find genital and prostate problems, and evaluate metabolic bone diseases.

Ultrasound Devices Market Trends:

At present, there is a rise in the adoption of ultrasound devices for diagnostic imaging and treatment across the globe. This, along with the growing prevalence of chronic and lifestyle disorders among the masses, represents one of the key factors driving the market. In addition, the escalating demand for minimally invasive surgery due to less pain, a shorter hospital stay, and fewer complications are contributing to the growth of the market. Besides this, the integration of artificial intelligence (Al) in ultrasound devices to automate time-consuming processes, such as quantification and selecting the best image slice from a 3D dataset, is positively influencing the market. Moreover, the increasing application of ultrasound devices in 3D imaging, shear wave elastography, development of wireless transducers, app-based ultrasound technology, fusion with CT/MR, and laparoscopic ultrasound is propelling the growth of the market. Apart from this, there is an increase in the demand for handheld ultrasound devices to treat critical care patients in crowded hospitals due to their speed, portability, and ease of use. This, along with the burgeoning healthcare industry, is bolstering the growth of the market around the world.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global ultrasound devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, device display type, device portability, application and end use.

Breakup by Product Type:

• Diagnostic Ultrasound Systems
  • 2D Imaging Systems
  • 3D and 4D Imaging Systems
  • Doppler Imaging
• Therapeutic Ultrasound Systems
  • High-Intensity Focused Ultrasound (HIFU)
  • Extracorporeal Shockwave Lithotripsy (ESWL)
     

Breakup by Device Display Type:

• Color Ultrasound Devices
• Black and White (B/W) Ultrasound Devices
   

Breakup by Device Portability:

• Trolley/Cart-Based Ultrasound Devices
• Compact/Handheld Ultrasound Devices
   

Breakup by Application:

• Radiology/General Imaging
• Obstetrics/Gynecology
• Cardiology
• Urology
• Vascular
• Others
   

Breakup by End Use:

• Hospitals
• Imaging Centers
• Research Centers
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Canon Medical Systems Corporation (Canon Inc.), CHISON Medical Technologies Co. Ltd., Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hologic Inc., Konica Minolta Inc., Koninklijke Philips N.V., Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.), Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthcare GmbH (Siemens AG) and Trivitron Healthcare.

Report Coverage: